Open claims vs. closed payer claims: What’s the difference?
Open claims and closed payer claims data are essential for understanding the status and activities...
Open claims and closed payer claims data are essential for understanding the status and activities...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where real-world data (RWD) fuels research, market access, and commercial decision-making, trust in data is everything. Yet, the growing presence of Zombie Data—da...